It looks like Vidya Balan’s ‘Tumhari Sulu’ has landed itself in a controversy!
The Food and Drug Administration (FDA), Maharashtra, may send notice to the film’s production house, T-Series and north India based pharmaceutical company, Torque, for not adding an advisory before promoting a cough syrup as a part of the film promotion.
Actress Vidya Balan will also get a notice from FDA for promoting the over-the-counter cough syrup via newspapers and electronic media.
“The movie campaign violated a basic norm - that of advising readers and audience to exercise caution while using the medicine. The notices point out that the advertisers have not warned the public against using the cough syrup without consulting their physician," Hindustan Times quoted FDA commissioner Pallavi Darade.
“We are aware that Torque pharma is behind both these products. We will definitely check the contents of the syrup and issue notices based on the complaint,” HT quoted Arjun Khadtare, FDA joint commissioner (drugs).
A medical activist Dr Tushar Jagtap, who brought the issue into the light to FDA said, “A drug is prescribed taking into consideration factors such as safety, efficacy, need of that particular molecule, the age of the patient, dosage schedule, drug interactions, history of allergy, and other important aspects.”
Vidya Balan was seen advertising the cough syrup during the promotions of the film. In an advertisement, she is coughing while anchoring a show at a radio station.
The actor in the advertisement says, “Sulu ke har safar mein uska saathi, Torex cough syrup ho, toh alvida khasi.”
Title Image: Youtube